logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
Amplite® Colorimetric Butyrylcholinesterase Activity Assay Kit
Butyrylcholinesterase (EC 3.1.1.8; BChE), also known as pseudocholinesterase or plasma cholinesterase, is mainly synthesized in liver and present in blood. BChE is a nonspecific cholinesterase enzyme and can hydrolyze many different choline esters, serving as the first line of defense against toxic compounds reaching the bloodstream. It has been identified as a clinical biomarker of organophosphate poisoning. Amplite® Colorimetric Butyrylcholinesterase Activity Assay Kit is based on a synthetic butyrylthiocholine-based substrate, which can be hydrolyzed by BChE and produce thiocholine. Thiocholine can react with 5, 5'-dithiobis (2-nitrobenzoic acid) (DTNB) and generates a yellow chromophore that can be detected at 410 nm. The assay is convenient, sensitive and can detect as low as 6 mU/mL in variety of samples.
Butyrylcholinesterase dose response was measured in a white/clear bottom 96-well plate with Amplite® Colorimetric Butyrylcholinesterase Assay Kit using a SpectraMax microplate reader. As low as 6.0 mU/mL of Butyrylcholinesterase can be detected with 10 minutes incubation (n=3).
Butyrylcholinesterase dose response was measured in a white/clear bottom 96-well plate with Amplite® Colorimetric Butyrylcholinesterase Assay Kit using a SpectraMax microplate reader. As low as 6.0 mU/mL of Butyrylcholinesterase can be detected with 10 minutes incubation (n=3).
CatalogSize
Price
Quantity
11406100 Tests
Price
 
Storage, safety and handling

Intended useResearch Use Only (RUO)
Instrument settings

Absorbance microplate reader
Absorbance410 ± 5 nm
Recommended plateClear bottom
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on October 13, 2025